SEC Form 4 · accession 0001214659-16-015013
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald J. Griffith
Director
Period of report
Nov 23, 2016
Accepted (ET)
Nov 28, 2016 · 9:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 23, 2016 | S | 1 | $3.75 | D | 144,926 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a portion of the number of shares to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on November 9, 2016.